CRISPR治療の初承認が、より精密なゲノム編集治療への道を開く。 CRISPR–Cas9技術を使ったゲノム編集治療が、2023年11月16日に世界で初めて英国で承認された。この治療法は、鎌状赤血球症と呼ばれる遺伝性血液疾患を治療する目的で遺伝子を無効化する。

CRISPRgenee is a new method that combines gene silencing and cutting to improve loss-of-function studies in human cells. (Nanowerk News) The 2020 Nobel Prize in Chemistry was awarded for the ...

Combining historical lessons with modern genetic technologies, scientists at the University of California San Diego have developed a new way to control and suppress populations of insects, potentially ...

Researchers have unveiled a way to flip genes back on without slicing into the genome, a shift that could make CRISPR far safer and more flexible. Instead of cutting DNA, the new approach scrubs away ...

The 2020 Nobel Prize in Chemistry was awarded for the development of CRISPR/Cas9, a method also known as “gene scissors”, which enables researchers to better understand how human cells function and ...

革新的な遺伝子編集技術CRISPRを開発したエマニュエル・シャルパンティエとジェニファー・ダウドナが、2020年のノーベル化学賞を共同受賞した。 CRISPR–Cas9遺伝子編集ツールを開発した功績を評価されるのは誰かという憶測がこの数年飛び交っていたが ...

Genetic editing holds promise to treat incurable diseases, but the most popular method — CRISPR — sometimes does more harm than good. A new study from University of California San Diego and Yale ...